Skip to content

Mettler-Toledo International

US · MTD #673 by market cap Listed 1970
1,666.88 -38.78 -2.27%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

✦ Quant Fair Value how this is computed

Near fair value
1,243.00 fair value ≈ 1,466.41 1,689.82
  • Implied fair-value range of 1,243.00-1,689.82, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is +13.7% above the average-multiple fair value of 1,466.41.

Valuation each multiple against its own 5-year range

P/B ratio 426.97 Expensive vs history 84th percentile
5-year average 190.80 · #41 of 41 in Diagnostics & Research
P/E ratio 36.18 In line with history 62nd percentile
5-year average 34.87 · forward 32.45 · #15 of 20 in Diagnostics & Research
P/S ratio 7.90 Expensive vs history 73rd percentile
5-year average 7.31 · forward 7.53 · #34 of 44 in Diagnostics & Research

Vs. peers Diagnostics & Research

Company Market cap P/E (TTM) P/B Div yield
Mettler-Toledo International (MTD) 33.15B 36.18 426.97 0.00%
Thermo Fisher Scientific (TMO) 248.08B 35.31 4.53 0.27%
Danaher (DHR) 155.03B 36.12 2.89 0.69%
IDEXX Laboratories Inc (IDXX) 53.28B 45.57 28.50 0.00%
Agilent Technologies (A) 48.04B 33.61 6.52 0.59%
Waters (WAT) 43.29B 184.29 2.83 0.00%

Other StockVane-tracked companies in the same industry.

Morningstar

★☆☆☆☆ Fair value1,351.44 Economic moatNarrow UncertaintyHigh

Trading 18.9% above Morningstar's fair value estimate.

Fair value

Mettler-Toledo International Inc receives a 1-star quantitative star rating, reflecting our opinion that this share class poses considerable downside risk. Those looking for diamonds in the rough should steer clear. The stock currently trades at a 26% premium over our quantitative fair value estimate of $1351.44 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating.

The company's valuation metrics undermine our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 0.2%, which sits in the bottom 10% compared with global peers. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which contributes to our view that shares are expensive.

The firm's lack of profitability is an additional cause for concern. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. The firm's earnings yield of 2.7%, a core component of profitability, ranks in the bottom 45% globally. The earnings generated by the company relative to its share price is concerning, which further promotes our unfavorable price/fair value ratio.

Economic moat

The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.

By Quantitative Equity Report

Quote time 2026-11-20 20:02:19 · For reference only, not investment advice and not tailored to your situation.

Mettler-Toledo International discussion 0 comments

Add a comment